@article{vergnenegre:hal-04176616,
TITLE = {Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo)},
AUTHOR = {Vergnenegre, Alain and Monnet, Isabelle and Ricordel, Charles and Bizieux, Acya and Curcio, Hubert and Bernardi, Marie and Corre, Romain and Guisier, Florian and Hominal, St{\'e}phane and Le Garff, Gwenaelle and Bylicki, Olivier and Locher, Chryst{\`e}le and Geier, Margaux and Choua{\"i}d, Christos and Robinet, Gilles},
URL = {https://hal.science/hal-04176616},
JOURNAL = {Lung Cancer},
PUBLISHER = {Elsevier},
VOLUME = {178},
PAGES = {191-197},
YEAR = {2023},
MONTH = Apr, DOI = {10.1016/j.lungcan.2023.02.020},
KEYWORDS = {Atezolizumab ; Immune check-point inhibitors ; Metastatic cancer ; Non-small cell lung cancer ; Phase II trial ; Vinorelbine},
HAL_ID = {hal-04176616},
HAL_VERSION = {v1},
}